IRIDEX Stock Price, News & Analysis (NASDAQ:IRIX)

$7.46 -0.13 (-1.71 %)
(As of 01/19/2018 04:00 PM ET)
Previous Close$7.46
Today's Range$7.40 - $8.00
52-Week Range$7.40 - $16.37
Volume36,554 shs
Average Volume14,160 shs
Market Capitalization$87.66 million
P/E RatioN/A
Dividend YieldN/A
Beta1.31

About IRIDEX (NASDAQ:IRIX)

IRIDEX logoIRIDEX Corporation is a provider of therapeutic based laser consoles, delivery devices and consumable instrumentation used to treat sight-threatening eye diseases in ophthalmology. The Company operates through ophthalmology segment. Its ophthalmology products consist of laser consoles, delivery devices and consumable instrumentation, including laser probes, and are used in the treatment of serious eye diseases, including the over three causes of irreversible blindness, such as diabetic retinopathy, glaucoma and age-related macular degeneration (AMD). In addition, the Company's ophthalmology products are often used in vitrectomy procedures (used to treat proliferative diabetic retinopathy, macular holes, retinal tears and detachments), which are generally performed in the operating room and require a consumable single use intraocular laser probe (EndoProbe) to deliver light to the back of the eye together with other instrumentation.

Receive IRIX News and Ratings via Email

Sign-up to receive the latest news and ratings for IRIX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Advanced Medical Equipment & Technology
Sub-IndustryN/A
SectorComputer and Technology
SymbolNASDAQ:IRIX
CUSIPN/A
Phone650-940-4700

Debt

Debt-to-Equity RatioN/A
Current Ratio5.38%
Quick Ratio4.00%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$46.16 million
Price / Sales1.87
Cash FlowN/A
Price / CashN/A
Book Value$3.47 per share
Price / Book2.15

Profitability

Trailing EPS($1.71)
Net Income$-11,710,000.00
Net Margins-42.22%
Return on Equity-23.21%
Return on Assets-19.03%

Miscellaneous

Employees121
Outstanding Shares11,580,000

IRIDEX (NASDAQ:IRIX) Frequently Asked Questions

What is IRIDEX's stock symbol?

IRIDEX trades on the NASDAQ under the ticker symbol "IRIX."

How were IRIDEX's earnings last quarter?

IRIDEX Co. (NASDAQ:IRIX) released its quarterly earnings results on Thursday, November, 2nd. The medical equipment provider reported ($0.27) earnings per share (EPS) for the quarter. IRIDEX had a negative return on equity of 23.21% and a negative net margin of 42.22%. View IRIDEX's Earnings History.

When will IRIDEX make its next earnings announcement?

IRIDEX is scheduled to release their next quarterly earnings announcement on Wednesday, March, 14th 2018. View Earnings Estimates for IRIDEX.

Where is IRIDEX's stock going? Where will IRIDEX's stock price be in 2018?

1 brokers have issued twelve-month price targets for IRIDEX's stock. Their forecasts range from $13.00 to $13.00. On average, they anticipate IRIDEX's share price to reach $13.00 in the next year. View Analyst Ratings for IRIDEX.

Who are some of IRIDEX's key competitors?

Who are IRIDEX's key executives?

IRIDEX's management team includes the folowing people:

  • William M. Moore Jr., Chairman of the Board, Interim President and Chief Executive Officer (Age 66)
  • Atabak Mokari, Chief Financial Officer, Vice President - Corporate Development (Age 39)
  • George R. Marcellino PhD, Director (Age 66)
  • Ann D. Rhoads, Director (Age 51)
  • Sanford Fitch, Independent Director (Age 76)
  • Ruediger Naumann-Etienne Ph.D., Independent Director (Age 69)

How do I buy IRIDEX stock?

Shares of IRIDEX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is IRIDEX's stock price today?

One share of IRIDEX stock can currently be purchased for approximately $7.46.

How big of a company is IRIDEX?

IRIDEX has a market capitalization of $87.66 million and generates $46.16 million in revenue each year. The medical equipment provider earns $-11,710,000.00 in net income (profit) each year or ($1.71) on an earnings per share basis. IRIDEX employs 121 workers across the globe.

How can I contact IRIDEX?

IRIDEX's mailing address is 1212 Terra Bella Avenue, Mountain View CA, 94043. The medical equipment provider can be reached via phone at 650-940-4700 or via email at [email protected]


MarketBeat Community Rating for IRIDEX (IRIX)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  81 (Vote Outperform)
Underperform Votes:  80 (Vote Underperform)
Total Votes:  161
MarketBeat's community ratings are surveys of what our community members think about IRIDEX and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

IRIDEX (NASDAQ:IRIX) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $13.00$13.00$20.00$20.00
Price Target Upside: 52.22% upside52.22% upside51.29% upside51.29% upside

IRIDEX (NASDAQ:IRIX) Consensus Price Target History

Price Target History for IRIDEX (NASDAQ:IRIX)

IRIDEX (NASDAQ:IRIX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/3/2017Roth CapitalReiterated RatingBuy -> Buy$13.00N/AView Rating Details
1/26/2016Singular ResearchInitiated CoverageBuy$11.50N/AView Rating Details
(Data available from 1/20/2016 forward)

Earnings

IRIDEX (NASDAQ:IRIX) Earnings History and Estimates Chart

Earnings by Quarter for IRIDEX (NASDAQ:IRIX)

IRIDEX (NASDAQ IRIX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/6/2018($0.21)N/AView Earnings Details
11/2/2017Q3 2017($0.27)ViewN/AView Earnings Details
8/3/2017Q2 2017($0.18)($0.24)$10.48 million$10.00 millionViewListenView Earnings Details
5/3/2017Q1 2017($0.18)($0.16)$10.62 million$10.48 millionViewListenView Earnings Details
3/8/2017Q4 2016($0.03)($0.11)ViewN/AView Earnings Details
11/3/2016Q316($0.03)($0.07)$11.20 million$9.79 millionViewListenView Earnings Details
8/4/2016Q216$0.01($0.03)$11.90 million$11.90 millionViewListenView Earnings Details
5/5/2016Q116$0.04$0.01$11.88 million$11.90 millionViewListenView Earnings Details
3/3/2016Q415$0.04$0.04$11.80 million$12.10 millionViewListenView Earnings Details
11/5/2015Q315$0.04$10.10 million$9.80 millionViewListenView Earnings Details
8/6/2015Q215($0.07)$10.60 million$9.00 millionViewListenView Earnings Details
5/7/2015Q115$0.02$10.30 million$10.80 millionViewListenView Earnings Details
3/5/2015Q4 2014$0.86ViewN/AView Earnings Details
10/30/2014Q3 2014$0.05ViewN/AView Earnings Details
7/31/2014Q2 2014$0.03ViewN/AView Earnings Details
5/1/2014Q1$0.06$0.05$8.90 million$10.30 millionViewListenView Earnings Details
2/27/2014Q4$0.04$0.04ViewListenView Earnings Details
10/31/2013Q3 2013$0.04$0.05ViewN/AView Earnings Details
8/1/2013Q2 2013$0.04$0.04ViewN/AView Earnings Details
5/2/2013Q1 2013$0.09ViewN/AView Earnings Details
2/28/2013Q4 2012$0.03ViewN/AView Earnings Details
11/1/2012Q3 2012($0.06)ViewN/AView Earnings Details
8/2/2012Q2 2012$0.04ViewN/AView Earnings Details
5/3/2012Q1 2012($0.03)ViewN/AView Earnings Details
11/3/2011Q3 2011$0.03ViewN/AView Earnings Details
8/4/2011Q2 2011$0.09ViewN/AView Earnings Details
5/5/2011Q1 2011$0.06ViewN/AView Earnings Details
3/3/2011Q4 2010$0.08ViewN/AView Earnings Details
11/4/2010Q3 2010$0.09ViewN/AView Earnings Details
8/5/2010Q2 2010$0.08ViewN/AView Earnings Details
5/6/2010Q1 2010$0.06ViewN/AView Earnings Details
3/4/2010Q4 2009$0.06ViewN/AView Earnings Details
11/12/2009Q3 2009$0.07ViewN/AView Earnings Details
8/13/2009Q2 2009$0.13ViewN/AView Earnings Details
5/14/2009Q1 2009$0.03ViewN/AView Earnings Details
3/10/2009Q4 2008($0.13)ViewN/AView Earnings Details
11/4/2008Q3 2008($0.03)ViewN/AView Earnings Details
8/12/2008Q2 2008$0.03ViewN/AView Earnings Details
5/13/2008Q1 2008($0.10)ViewN/AView Earnings Details
4/10/2008Q4 2007($0.72)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

IRIDEX (NASDAQ:IRIX) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.87 EPS
Next Year EPS Consensus Estimate: $-0.8 EPS

Dividends

Dividend History for IRIDEX (NASDAQ:IRIX)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

IRIDEX (NASDAQ IRIX) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 5.01%
Institutional Ownership Percentage: 49.31%
Insider Trades by Quarter for IRIDEX (NASDAQ:IRIX)
Institutional Ownership by Quarter for IRIDEX (NASDAQ:IRIX)

IRIDEX (NASDAQ IRIX) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/12/2017William M MooreCEOBuy5,000$7.84$39,200.00View SEC Filing  
9/15/2017William M MooreChairmanBuy1,800$9.42$16,956.00372,434View SEC Filing  
3/15/2017Romeo R DizonInsiderSell2,811$13.16$36,992.7617,289View SEC Filing  
11/16/2016Romeo R DizonInsiderSell584$16.04$9,367.3620,434View SEC Filing  
9/12/2016Romeo R DizonInsiderSell125$15.00$1,875.0020,163View SEC Filing  
9/7/2016Ruediger Naumann-EtienneDirectorSell9,513$14.75$140,316.7571,433View SEC Filing  
9/2/2016Ruediger Naumann-EtienneDirectorSell2,513$14.73$37,016.4971,433View SEC Filing  
8/23/2016Romeo R DizonInsiderSell875$14.52$12,705.0020,975View SEC Filing  
8/19/2016Romeo R DizonInsiderSell7,896$13.52$106,753.9220,123View SEC Filing  
8/16/2016George R MarcellinoDirectorSell2,513$13.57$34,101.411,289View SEC Filing  
8/16/2016Romeo R DizonInsiderSell839$13.70$11,494.3020,100View SEC Filing  
6/6/2016Ronald SteckelVPSell625$13.52$8,450.0066,250View SEC Filing  
5/17/2016Ronald SteckelVPSell4,583$12.81$58,708.2368,958View SEC Filing  
3/8/2016Ronald SteckelVPSell12,000$10.45$125,400.0075,125View SEC Filing  
11/19/2015William M MooreCEOBuy10,000$9.83$98,300.00290,931View SEC Filing  
9/25/2015Associates & Paragon A ParagonMajor ShareholderBuy52,042$7.05$366,896.10View SEC Filing  
9/10/2015Associates & Paragon A ParagonMajor ShareholderBuy11,866$6.95$82,468.70View SEC Filing  
9/4/2015Associates & Paragon A ParagonMajor ShareholderBuy10,304$6.81$70,170.24View SEC Filing  
9/2/2015Ronald SteckelVPSell1,875$6.80$12,750.0028,875View SEC Filing  
8/21/2015Associates & Paragon A ParagonMajor ShareholderBuy20,651$7.16$147,861.16View SEC Filing  
8/19/2015James H. MackanessCFOSell2,373$7.15$16,966.9545,052View SEC Filing  
8/19/2015Ronald SteckelVPSell1,751$7.14$12,502.1428,875View SEC Filing  
8/18/2015James H. MackanessCFOSell2,627$7.10$18,651.7044,558View SEC Filing  
8/17/2015James H. MackanessCFOSell2,235$7.05$15,756.7544,558View SEC Filing  
8/14/2015James H MackanessCFOSell7,765$6.99$54,277.35View SEC Filing  
8/14/2015Ronald SteckelVPSell1,458$7.00$10,206.00View SEC Filing  
7/24/2015Associates & Paragon A ParagonMajor ShareholderBuy40,403$7.01$283,225.03View SEC Filing  
6/17/2015Ronald SteckelVPSell1,666$8.77$14,610.82View SEC Filing  
5/20/2015James H MackanessCFOSell2,000$9.80$19,600.00View SEC Filing  
5/18/2015Ronald SteckelVPSell1,667$9.33$15,553.11View SEC Filing  
4/20/2015Ronald SteckelVPSell1,447$9.79$14,166.13View SEC Filing  
4/17/2015Ronald SteckelVPSell1,667$9.86$16,436.62View SEC Filing  
3/17/2015Ronald SteckelVPSell11,358$10.08$114,488.64View SEC Filing  
3/10/2015Ronald SteckelVPSell1,250$10.03$12,537.50View SEC Filing  
2/17/2015Ronald SteckelVPSell1,650$9.79$16,153.50View SEC Filing  
1/20/2015Ronald SteckelVPSell1,650$9.03$14,899.50View SEC Filing  
12/17/2014Ronald SteckelVPSell1,650$8.52$14,058.00View SEC Filing  
11/17/2014Ronald SteckelVPSell1,650$8.28$13,662.00View SEC Filing  
11/6/2014William M MooreDirectorBuy5,000$7.79$38,950.00View SEC Filing  
10/12/2014Catalyst Fund Ix L.P BluelineDirectorBuy17,237$8.11$139,792.07View SEC Filing  
10/10/2014Catalyst Fund Ix L.P BluelineDirectorBuy12,798$8.02$102,639.96View SEC Filing  
9/5/2014Catalyst Fund Ix L.P BluelineDirectorBuy8,432$7.99$67,371.68View SEC Filing  
8/29/2014Catalyst Fund Ix L.P BluelineDirectorBuy4,272$7.92$33,834.24View SEC Filing  
8/22/2014James B HawkinsDirectorSell600$8.03$4,818.00View SEC Filing  
8/18/2014Ronald SteckelVPSell1,650$8.00$13,200.00View SEC Filing  
8/15/2014James B HawkinsDirectorSell14,400$8.10$116,640.00View SEC Filing  
8/14/2014James B HawkinsDirectorSell2,714$8.08$21,929.12View SEC Filing  
8/13/2014James B HawkinsDirectorSell9,786$8.11$79,364.46View SEC Filing  
8/11/2014Garrett A GarrettsonDirectorSell2,810$8.30$23,323.00View SEC Filing  
7/31/2014Ronald SteckelVPSell761$8.00$6,088.00View SEC Filing  
7/21/2014James H MackanessCFOSell1,000$7.62$7,620.00View SEC Filing  
6/23/2014James H MackanessCFOSell2,000$8.24$16,480.00View SEC Filing  
6/17/2014Ronald SteckelVPSell1,650$8.20$13,530.00View SEC Filing  
6/6/2014Catalyst Fund Ix L.P BluelineDirectorBuy7,390$8.32$61,484.80View SEC Filing  
6/3/2014William M MooreCEOBuy5,000$8.48$42,400.00View SEC Filing  
5/21/2014James H MackanessCFOSell3,000$8.73$26,190.00View SEC Filing  
5/19/2014Ronald SteckelVPSell1,650$8.82$14,553.00View SEC Filing  
5/9/2014William M MooreCEOBuy5,000$8.40$42,000.00View SEC Filing  
4/22/2014James H MackanessCFOSell4,000$8.74$34,960.00View SEC Filing  
4/17/2014Ronald SteckelVPSell1,650$8.88$14,652.00View SEC Filing  
3/21/2014James H MackanessCFOSell4,000$9.03$36,120.00View SEC Filing  
3/17/2014Ronald SteckelVPSell1,650$9.07$14,965.50View SEC Filing  
2/18/2014Ronald SteckelVPSell1,650$8.60$14,190.00View SEC Filing  
1/17/2014Ronald SteckelVPSell1,650$10.42$17,193.00View SEC Filing  
12/17/2013Ronald SteckelVPSell1,650$8.56$14,124.00View SEC Filing  
12/2/2013James H MackanessCFOSell10,000$10.52$105,200.00View SEC Filing  
9/6/2013Ruediger Naumann-EtienneDirectorBuy3,600$5.99$21,564.00View SEC Filing  
8/9/2013William M MooreCEOBuy10,000$5.88$58,800.00View SEC Filing  
6/19/2013Eduardo AriasVPSell22,768$5.43$123,630.24View SEC Filing  
6/18/2013James H MackanessCFOSell19,862$4.58$90,967.96View SEC Filing  
6/17/2013Eduardo AriasVPSell4,532$5.39$24,427.48View SEC Filing  
6/14/2013James H MackanessCFOSell10,568$5.38$56,855.84View SEC Filing  
6/13/2013James H MackanessCFOSell1,400$5.30$7,420.00View SEC Filing  
6/11/2013Eduardo AriasVPSell1,000$5.61$5,610.00View SEC Filing  
6/11/2013James H MackanessCFOSell1,200$5.61$6,732.00View SEC Filing  
6/10/2013Eduardo AriasVPSell2,400$5.38$12,912.00View SEC Filing  
6/10/2013James H MackanessCFOSell6,970$5.36$37,359.20View SEC Filing  
6/6/2013William M MooreCEOBuy2,000$5.42$10,840.00View SEC Filing  
5/17/2013Eduardo AriasVPSell10,000$6.30$63,000.00View SEC Filing  
3/8/2013Ruediger Naumann-EtienneDirectorBuy2,400$4.80$11,520.00View SEC Filing  
3/7/2013William M MooreCEOBuy10,000$4.66$46,600.00View SEC Filing  
9/6/2012William M MooreCEOBuy10,000$3.76$37,600.00View SEC Filing  
8/15/2012Catalyst Fund Ix L.P BluelineMajor ShareholderBuy60,900$3.19$194,271.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

IRIDEX (NASDAQ IRIX) News Headlines

Source:
DateHeadline
Head-To-Head Analysis: Mazor Robotics (MZOR) and IRIDEX (IRIX)Head-To-Head Analysis: Mazor Robotics (MZOR) and IRIDEX (IRIX)
www.americanbankingnews.com - January 19 at 5:32 PM
IRIDEX Announces Infringement Lawsuit Against QuantelIRIDEX Announces Infringement Lawsuit Against Quantel
finance.yahoo.com - January 9 at 11:18 AM
Zacks: Brokerages Set $13.00 Target Price for IRIDEX Co. (IRIX)Zacks: Brokerages Set $13.00 Target Price for IRIDEX Co. (IRIX)
www.americanbankingnews.com - January 8 at 5:34 PM
IRIDEX Announces Preliminary Operational and Financial Results for 2017 Fourth Quarter and Full YearIRIDEX Announces Preliminary Operational and Financial Results for 2017 Fourth Quarter and Full Year
finance.yahoo.com - January 8 at 11:00 AM
What Are Analysts Saying About IRIDEX Corporation’s (NASDAQ:IRIX) Future?What Are Analysts Saying About IRIDEX Corporation’s (NASDAQ:IRIX) Future?
finance.yahoo.com - January 6 at 9:16 AM
What You Must Know About IRIDEX Corporation’s (NASDAQ:IRIX) Financial HealthWhat You Must Know About IRIDEX Corporation’s (NASDAQ:IRIX) Financial Health
finance.yahoo.com - December 29 at 10:56 AM
ETFs with exposure to IRIDEX Corp. : December 27, 2017ETFs with exposure to IRIDEX Corp. : December 27, 2017
finance.yahoo.com - December 27 at 1:28 PM
IRIDEX Corp. :IRIX-US: Earnings Analysis: Q3, 2017 By the Numbers : December 25, 2017IRIDEX Corp. :IRIX-US: Earnings Analysis: Q3, 2017 By the Numbers : December 25, 2017
finance.yahoo.com - December 25 at 4:11 PM
IRIDEX (IRIX) Upgraded at Zacks Investment ResearchIRIDEX (IRIX) Upgraded at Zacks Investment Research
www.americanbankingnews.com - December 21 at 12:14 AM
 IRIDEX Co. (IRIX) Receives Consensus Rating of "Strong Buy" from Analysts IRIDEX Co. (IRIX) Receives Consensus Rating of "Strong Buy" from Analysts
www.americanbankingnews.com - December 16 at 11:30 AM
William M. Moore Acquires 5,000 Shares of IRIDEX Co. (IRIX) StockWilliam M. Moore Acquires 5,000 Shares of IRIDEX Co. (IRIX) Stock
www.americanbankingnews.com - December 15 at 9:44 PM
IRIDEX (IRIX) & Accelerate Diagnostics (AXDX) Head-To-Head ComparisonIRIDEX (IRIX) & Accelerate Diagnostics (AXDX) Head-To-Head Comparison
www.americanbankingnews.com - December 4 at 1:34 AM
Head to Head Review: Digirad (DRAD) & IRIDEX (IRIX)Head to Head Review: Digirad (DRAD) & IRIDEX (IRIX)
www.americanbankingnews.com - November 29 at 9:44 PM
Brokerages Anticipate IRIDEX Corporation (IRIX) to Announce ($0.21) Earnings Per ShareBrokerages Anticipate IRIDEX Corporation (IRIX) to Announce ($0.21) Earnings Per Share
www.americanbankingnews.com - November 28 at 7:56 AM
Critical Analysis: IRIDEX Corporation (IRIX) & Mindray Medical International (MR)Critical Analysis: IRIDEX Corporation (IRIX) & Mindray Medical International (MR)
www.americanbankingnews.com - November 18 at 5:20 PM
Comparing Digirad Corporation (DRAD) and IRIDEX Corporation (IRIX)Comparing Digirad Corporation (DRAD) and IRIDEX Corporation (IRIX)
www.americanbankingnews.com - November 9 at 3:38 AM
IRIDEX Corporation (IRIX) Now Covered by Analysts at Roth CapitalIRIDEX Corporation (IRIX) Now Covered by Analysts at Roth Capital
www.americanbankingnews.com - November 3 at 10:48 AM
Edited Transcript of IRIX earnings conference call or presentation 2-Nov-17 9:00pm GMTEdited Transcript of IRIX earnings conference call or presentation 2-Nov-17 9:00pm GMT
finance.yahoo.com - November 3 at 8:44 AM
ETFs with exposure to IRIDEX Corp. : October 27, 2017ETFs with exposure to IRIDEX Corp. : October 27, 2017
finance.yahoo.com - October 28 at 7:08 AM
IRIDEX to Present at Upcoming Investor ConferencesIRIDEX to Present at Upcoming Investor Conferences
finance.yahoo.com - October 26 at 7:37 PM
IRIDEX Corporation (IRIX) Scheduled to Post Earnings on ThursdayIRIDEX Corporation (IRIX) Scheduled to Post Earnings on Thursday
www.americanbankingnews.com - October 26 at 6:10 AM
IRIDEX to Report Third Quarter 2017 Financial Results on November 2, 2017IRIDEX to Report Third Quarter 2017 Financial Results on November 2, 2017
finance.yahoo.com - October 20 at 12:40 AM
ETFs with exposure to IRIDEX Corp. : October 9, 2017ETFs with exposure to IRIDEX Corp. : October 9, 2017
finance.yahoo.com - October 9 at 8:00 PM
IRIDEX Corp. :IRIX-US: Earnings Analysis: Q2, 2017 By the Numbers : October 6, 2017IRIDEX Corp. :IRIX-US: Earnings Analysis: Q2, 2017 By the Numbers : October 6, 2017
finance.yahoo.com - October 6 at 11:55 PM
Analyzing IRIDEX Corporation (IRIX) and Thermo Fisher Scientific (TMO)Analyzing IRIDEX Corporation (IRIX) and Thermo Fisher Scientific (TMO)
www.americanbankingnews.com - September 30 at 12:26 PM
IRIDEX Corporation (IRIX) Chairman Buys $16,956.00 in StockIRIDEX Corporation (IRIX) Chairman Buys $16,956.00 in Stock
www.americanbankingnews.com - September 18 at 8:32 PM
Analyzing IRIDEX Corporation (IRIX) and Alliance HealthCare Services (AIQ)Analyzing IRIDEX Corporation (IRIX) and Alliance HealthCare Services (AIQ)
www.americanbankingnews.com - September 18 at 12:30 AM
IRIDEX Corporation (IRIX) & Its Rivals Head to Head AnalysisIRIDEX Corporation (IRIX) & Its Rivals Head to Head Analysis
www.americanbankingnews.com - September 17 at 8:30 PM
Is It The Right Time To Buy IRIDEX Corporation (IRIX)?Is It The Right Time To Buy IRIDEX Corporation (IRIX)?
finance.yahoo.com - September 11 at 8:42 PM
Critical Survey: IRIDEX Corporation (IRIX) & The CompetitionCritical Survey: IRIDEX Corporation (IRIX) & The Competition
www.americanbankingnews.com - September 9 at 2:08 PM
Head to Head Survey: Illumina (ILMN) and IRIDEX Corporation (IRIX)Head to Head Survey: Illumina (ILMN) and IRIDEX Corporation (IRIX)
www.americanbankingnews.com - September 9 at 4:06 AM
Financial Analysis: IRIDEX Corporation (IRIX) versus Viveve Medical (VIVE)Financial Analysis: IRIDEX Corporation (IRIX) versus Viveve Medical (VIVE)
www.americanbankingnews.com - September 5 at 8:34 AM
Critical Analysis: IRIDEX Corporation (IRIX) vs. Cogentix Medical (CGNT)Critical Analysis: IRIDEX Corporation (IRIX) vs. Cogentix Medical (CGNT)
www.americanbankingnews.com - August 26 at 12:18 PM
Head-To-Head Contrast: IRIDEX Corporation (IRIX) vs. Waters Corporation (WAT)Head-To-Head Contrast: IRIDEX Corporation (IRIX) vs. Waters Corporation (WAT)
www.americanbankingnews.com - August 19 at 12:30 PM
Financial Comparison: IRIDEX Corporation (IRIX) and Varian Medical Systems (VAR)Financial Comparison: IRIDEX Corporation (IRIX) and Varian Medical Systems (VAR)
www.americanbankingnews.com - August 4 at 10:16 PM
Edited Transcript of IRIX earnings conference call or presentation 3-Aug-17 9:00pm GMTEdited Transcript of IRIX earnings conference call or presentation 3-Aug-17 9:00pm GMT
finance.yahoo.com - August 4 at 8:14 PM
IRIDEX Announces 2017 Second Quarter, Six-Month Financial ResultsIRIDEX Announces 2017 Second Quarter, Six-Month Financial Results
finance.yahoo.com - August 4 at 1:10 AM
IRIDEX to Report Second Quarter 2017 Financial Results on August 3, 2017IRIDEX to Report Second Quarter 2017 Financial Results on August 3, 2017
finance.yahoo.com - July 20 at 11:57 PM
IRIDEX Announces Appointment Of Ann Rhoads To Its Board Of DirectorsIRIDEX Announces Appointment Of Ann Rhoads To Its Board Of Directors
finance.yahoo.com - July 18 at 4:51 PM
IRIDEX Corporation (NASDAQ:IRIX) Sees Significant Decrease in Short InterestIRIDEX Corporation (NASDAQ:IRIX) Sees Significant Decrease in Short Interest
www.americanbankingnews.com - July 17 at 7:20 AM
Iridex reports 1Q lossIridex reports 1Q loss
marketbeat.com - May 3 at 6:05 PM
IRIDEX CORP Files SEC form 10-K, Annual ReportIRIDEX CORP Files SEC form 10-K, Annual Report
biz.yahoo.com - March 15 at 6:16 PM
IRIDEX CORP Files SEC form 8-K, Change in Directors or Principal OfficersIRIDEX CORP Files SEC form 8-K, Change in Directors or Principal Officers
biz.yahoo.com - March 13 at 5:49 PM
Q4 2016 IRIDEX Corp Earnings Release - After Market CloseQ4 2016 IRIDEX Corp Earnings Release - After Market Close
us.rd.yahoo.com - March 8 at 6:44 PM
IRIDEX Announces Fourth Quarter and 2016 Financial Results and Provides Full Year 2017 Financial OutlookIRIDEX Announces Fourth Quarter and 2016 Financial Results and Provides Full Year 2017 Financial Outlook
us.rd.yahoo.com - March 8 at 6:44 PM
IRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsIRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
biz.yahoo.com - January 10 at 6:51 PM
IRIDEX Announces Preliminary Unaudited Revenues for 2016 Fourth Quarter and Full YearIRIDEX Announces Preliminary Unaudited Revenues for 2016 Fourth Quarter and Full Year
www.prnewswire.com - January 9 at 6:44 PM
IRIDEX announces preliminary revenues for Q4 and FY2016IRIDEX announces preliminary revenues for Q4 and FY2016
seekingalpha.com - January 9 at 6:44 PM
IRIDEX CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements and ExIRIDEX CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements and Ex
biz.yahoo.com - December 14 at 6:37 PM
IRIDEX Corporation Prices Public Offering of Common StockIRIDEX Corporation Prices Public Offering of Common Stock
www.bizjournals.com - December 9 at 9:48 AM

SEC Filings

IRIDEX (NASDAQ:IRIX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

IRIDEX (NASDAQ:IRIX) Income Statement, Balance Sheet and Cash Flow Statement

Chart

IRIDEX (NASDAQ IRIX) Stock Chart for Saturday, January, 20, 2018

Loading chart…

This page was last updated on 1/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.